Long-term outcome of reoperations for medullary thyroid carcinoma

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 754-765

  Fialkowski, Elizabeth ^a   Debenedetti, Mary ^a   Moley, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FAMILIAL CANCER; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MICRODISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REOPERATION; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 42449107686     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9317-7     Document Type: Article

References (24)

1. Al-Rawi M, Wheeler MH (2006) Medullary thyroid carcinoma-update and present management controversies. Ann R Coll Surg Engl 88:433-438
2. Farndon JR, Leight GS, Dilley WG et al (1986) Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 73:278-281
3. Wells SA, Baylin SB, Linehan WM et al (1978) Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg 188:139-141
4. Moley JF, Wells SA, Dilley WG et al (1993) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090-1095
5. Chong GC, Beahrs OH, Sizemore GW et al (1975) Medullary carcinoma of the thyroid gland. Cancer 35:695-704
6. Block MA, Jackson CE, Tashjian AH (1978) Management of occult medullary thyroid carcinoma: evidenced only by serum calcitonin elevations after apparently adequate neck operations. Arch Surg 113:368-372
7. Block MA, Jackson CE, Greenawald KA et al (1980) Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Arch Surg 115:142-148
8. Fialkowski EA, Moley JF (2006) Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol 94:737-747
9. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562-567; discussion 567-568
10. Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 122:1124-1130; discussion 1130-1131
11. Yen TWF, Shapiro SE, Gagel RF et al. (2003) Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 134:890-899; discussion 899-901
12. Tisell LE, Hansson G, Jansson S et al (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60-66
13. Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112-121
14. Moley JF, Dilley WG, DeBenedetti MK (1997) Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 225:734-740
15. Greene FL, Page DL, Fleming ID, et al (2002) AJCC Cancer Staging Manual, 6th edition, New York, Springer-Verlag, p. 77-79
16. Melvin KE, Miller HH, Tashjian AH (1971) Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med 285:1115-1120
17. Van Heerden JA, Grant CS, Gharib H et al (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-401
18. Norton JA, Doppman JL, Brennan MF (1980) Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87:616-622
19. Frank-Raue K, Raue F, Buhr HJ et al (1992) Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2:113-117
20. Modigliani E, Cohen R, Campos JM et al (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine. Clin Endocrinol (Oxf) 48:265-273
21. Scopsi L, Sampietro G, Boracchi P et al (1996) Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer 78:2173-2183
22. Gulben K, Berberoglu U, Boyabatl M (2006) Prognostic factors for sporadic medullary thyroid carcinoma. World J Surg 30:84-90
23. Dottorini ME, Assi A, Sironi M et al (1996) Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556-1565
24. Machens A, Gimm O, Ukkat J et al (2000) Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88:1909-1915